• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖小鼠的前列腺周围脂肪组织(PPAT)上清液释放抗收缩物质并增加人前列腺上皮细胞增殖:一氧化氮和腺苷的作用。

Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine.

作者信息

Passos Gabriela Reolon, de Oliveira Mariana G, Ghezzi Ana Carolina, Mello Glaucia C, Levi D'Ancona Carlos Arturo, Teixeira Simone Aparecida, Muscará Marcelo Nicolas, Grespan Bottoli Carla Beatriz, Vilela de Melo Lucilia, de Oliveira Eliezer, Antunes Edson, Mónica Fabiola Zakia

机构信息

Section of Pharmacology, Department of Translational Medicine, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.

Division of Urology, Department of Surgery, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.

出版信息

Front Pharmacol. 2023 Jul 10;14:1145860. doi: 10.3389/fphar.2023.1145860. eCollection 2023.

DOI:10.3389/fphar.2023.1145860
PMID:37492091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10364323/
Abstract

The prostate gland is surrounded by periprostatic adipose tissue (PPAT) that can release mediators that interfere in prostate function. In this study, we examined the effect of periprostatic adipose tissue supernatant obtained from obese mice on prostate reactivity and on the viability of human prostatic epithelial cell lines. Male C57BL/6 mice were fed a standard or high-fat diet after which PPAT was isolated, incubated in Krebs-Henseleit solution for 30 min (without prostate) or 60 min (with prostate), and the supernatant was then collected and screened for biological activity. Total nitrate and nitrite (NOx) and adenosine were quantified, and the supernatant was then collected and screened for biological activity. NOx and adenosine were quantified. Concentration-response curves to phenylephrine (PE) were obtained in prostatic tissue from lean and obese mice incubated with or without periprostatic adipose tissue. In some experiments, periprostatic adipose tissue was co-incubated with inhibitors of the nitric oxide (NO)-cyclic guanosine monophosphate pathway (L-NAME, 1400W, ODQ), adenylate cyclase (SQ22536) or with adenosine A (ZM241385), and A (MRS1754) receptor antagonists. PNT1-A (normal) and BPH-1 (hyperplasic) human epithelial cells were cultured and incubated with supernatant from periprostatic adipose tissue for 24, 48, or 72 h in the absence or presence of these inhibitors/antagonists, after which cell viability and proliferation were assessed. The levels of NOx and adenosine were significantly higher in the periprostatic adipose tissue supernatant (30 min, without prostate) when compared to the vehicle. A trend toward an increase in the levels of NOX was observed after 60 min. PPAT supernatant from obese mice significantly reduced the PE-induced contractions only in prostate from obese mice. The co-incubation of periprostatic adipose tissue with L-NAME, 1400W, ODQ, or ZM241385 attenuated the anticontractile activity of the periprostatic adipose tissue supernatant. Incubation with the supernatant of periprostatic adipose tissue from obese mice significantly increased the viability of PNT1-A cells and attenuated expression of the apoptosis marker protein caspase-3 when compared to cells incubated with periprostatic adipose tissue from lean mice. Hyperplastic cells (BPH-1) incubated with periprostatic adipose tissue from obese mice showed greater proliferation after 24 h, 48 h, and 72 h compared to cells incubated with culture medium alone. BPH-1 cell proliferation in the presence of PPAT supernatant was attenuated by NO-signaling pathway inhibitors and by adenosine receptor antagonists after 72 h. NO and adenosine are involved in the anticontractile and pro-proliferative activities of periprostatic adipose tissue supernatant from obese mice. More studies are needed to determine whether the blockade of NO and/or adenosine derived from periprostatic adipose tissue can improve prostate function.

摘要

前列腺被前列腺周围脂肪组织(PPAT)所包围,该组织可释放干扰前列腺功能的介质。在本研究中,我们检测了从肥胖小鼠获取的前列腺周围脂肪组织上清液对前列腺反应性以及人前列腺上皮细胞系活力的影响。雄性C57BL/6小鼠分别喂食标准饮食或高脂饮食,之后分离PPAT,在Krebs-Henseleit溶液中孵育30分钟(无前列腺)或60分钟(有前列腺),然后收集上清液并检测其生物活性。对总硝酸盐和亚硝酸盐(NOx)以及腺苷进行定量,然后收集上清液并检测其生物活性。对NOx和腺苷进行定量。在有或无前列腺周围脂肪组织孵育的情况下,在瘦小鼠和肥胖小鼠的前列腺组织中获得对去氧肾上腺素(PE)的浓度-反应曲线。在一些实验中,将前列腺周围脂肪组织与一氧化氮(NO)-环磷酸鸟苷途径抑制剂(L-NAME、1400W、ODQ)、腺苷酸环化酶抑制剂(SQ22536)或与腺苷A(ZM241385)和A(MRS1754)受体拮抗剂共同孵育。培养正常的PNT1-A细胞和增生性的BPH-1人上皮细胞,并在有或无这些抑制剂/拮抗剂的情况下,用前列腺周围脂肪组织的上清液孵育24、48或72小时,之后评估细胞活力和增殖情况。与溶剂相比,前列腺周围脂肪组织上清液(30分钟,无前列腺)中的NOx和腺苷水平显著更高。孵育60分钟后观察到NOX水平有升高趋势。肥胖小鼠的PPAT上清液仅显著降低了肥胖小鼠前列腺中PE诱导的收缩。前列腺周围脂肪组织与L-NAME、1400W、ODQ或ZM241385共同孵育可减弱前列腺周围脂肪组织上清液的抗收缩活性。与用瘦小鼠的前列腺周围脂肪组织孵育的细胞相比,用肥胖小鼠的前列腺周围脂肪组织上清液孵育可显著提高PNT1-A细胞的活力,并减弱凋亡标记蛋白半胱天冬酶-3的表达。与仅用培养基孵育的细胞相比,用肥胖小鼠的前列腺周围脂肪组织孵育的增生性细胞(BPH-1)在24小时、48小时和72小时后显示出更强的增殖。72小时后,NO信号通路抑制剂和腺苷受体拮抗剂可减弱PPAT上清液存在时BPH-1细胞的增殖。NO和腺苷参与了肥胖小鼠前列腺周围脂肪组织上清液的抗收缩和促增殖活性。需要更多研究来确定阻断源自前列腺周围脂肪组织的NO和/或腺苷是否可改善前列腺功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/6169a503dabd/fphar-14-1145860-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/57c00b1ddd0a/fphar-14-1145860-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/54db272e9e7e/fphar-14-1145860-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/a3df8443f1e8/fphar-14-1145860-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/88aaa0ef0c07/fphar-14-1145860-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/575ac0807212/fphar-14-1145860-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/bc94ccb50475/fphar-14-1145860-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/7256d71b7fa2/fphar-14-1145860-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/6169a503dabd/fphar-14-1145860-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/57c00b1ddd0a/fphar-14-1145860-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/54db272e9e7e/fphar-14-1145860-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/a3df8443f1e8/fphar-14-1145860-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/88aaa0ef0c07/fphar-14-1145860-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/575ac0807212/fphar-14-1145860-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/bc94ccb50475/fphar-14-1145860-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/7256d71b7fa2/fphar-14-1145860-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02dc/10364323/6169a503dabd/fphar-14-1145860-g008.jpg

相似文献

1
Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine.肥胖小鼠的前列腺周围脂肪组织(PPAT)上清液释放抗收缩物质并增加人前列腺上皮细胞增殖:一氧化氮和腺苷的作用。
Front Pharmacol. 2023 Jul 10;14:1145860. doi: 10.3389/fphar.2023.1145860. eCollection 2023.
2
The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related Disorders.前列腺周围脂肪组织在血管相关疾病中对前列腺功能的作用。
Front Pharmacol. 2021 Feb 12;12:626155. doi: 10.3389/fphar.2021.626155. eCollection 2021.
3
Influence of the periprostatic adipose tissue in obesity-associated mouse urethral dysfunction and oxidative stress: Effect of resveratrol treatment.肥胖相关的小鼠尿道功能障碍和氧化应激中前列腺周围脂肪组织的影响:白藜芦醇治疗的作用。
Eur J Pharmacol. 2018 Oct 5;836:25-33. doi: 10.1016/j.ejphar.2018.08.010. Epub 2018 Aug 11.
4
Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.肥胖不会促进局部患者来源的前列腺癌异种移植瘤的肿瘤发生。
Oncotarget. 2016 Jul 26;7(30):47650-47662. doi: 10.18632/oncotarget.10258.
5
Tumoral periprostatic adipose tissue exovesicles-derived miR-20a-5p regulates prostate cancer cell proliferation and inflammation through the RORA gene.肿瘤前列腺周脂肪组织衍生的外泌体 miR-20a-5p 通过 RORA 基因调控前列腺癌细胞增殖和炎症。
J Transl Med. 2024 Jul 15;22(1):661. doi: 10.1186/s12967-024-05458-3.
6
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer.前列腺周围脂肪组织通过分泌凋亡因子抑制肿瘤进展:前列腺癌早期由免疫反应诱导的天然屏障。
Oncol Lett. 2024 Aug 8;28(4):485. doi: 10.3892/ol.2024.14617. eCollection 2024 Oct.
7
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer.对局限性前列腺癌男性患者前列腺周围和皮下脂肪组织脂肪分解及脂肪细胞大小的评估。
Cancers (Basel). 2020 May 28;12(6):1385. doi: 10.3390/cancers12061385.
8
Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer Progression.前列腺周脂肪组织微环境:前列腺癌进展过程中的代谢和激素途径。
Front Endocrinol (Lausanne). 2022 Apr 13;13:863027. doi: 10.3389/fendo.2022.863027. eCollection 2022.
9
Human periprostatic adipose tissue: its influence on prostate cancer cells.人前列腺周围脂肪组织:其对前列腺癌细胞的影响。
Cell Physiol Biochem. 2012;30(1):113-22. doi: 10.1159/000339051. Epub 2012 Jun 13.
10
Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissue.脂噬作用与前列腺癌:与疾病侵袭性和与前列腺周脂肪组织的接近程度相关。
J Pathol. 2021 Oct;255(2):166-176. doi: 10.1002/path.5754. Epub 2021 Aug 7.

引用本文的文献

1
Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model.鉴定肝细胞癌中与索拉非尼耐药相关的基因以建立风险模型。
Discov Oncol. 2025 Aug 20;16(1):1587. doi: 10.1007/s12672-025-03442-x.
2
Adenosine signaling: a potential therapeutic target for psychogenic erectile dysfunction.腺苷信号传导:心因性勃起功能障碍的潜在治疗靶点。
Am J Transl Res. 2024 Dec 15;16(12):7248-7261. doi: 10.62347/YZDZ1428. eCollection 2024.
3
Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database.

本文引用的文献

1
An evaluation of lower urinary tract symptoms in diabetic patients: a cross-sectional study.糖尿病患者下尿路症状评估:一项横断面研究。
BMC Urol. 2022 Nov 10;22(1):178. doi: 10.1186/s12894-022-01133-1.
2
Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.肥胖、生活方式因素与良性前列腺增生风险之间的因果关系:单变量和多变量孟德尔随机化研究。
J Transl Med. 2022 Oct 29;20(1):495. doi: 10.1186/s12967-022-03722-y.
3
Periprostatic Adipose Tissue Displays a Chronic Hypoxic State that Limits Its Expandability.
考察米拉贝隆的安全性:对来自美国食品药品监督管理局不良事件报告系统(FAERS)数据库的真实世界药物警戒数据的分析。
Front Pharmacol. 2024 Mar 18;15:1376535. doi: 10.3389/fphar.2024.1376535. eCollection 2024.
前列腺周围脂肪组织呈现出一种限制其扩张能力的慢性缺氧状态。
Am J Pathol. 2022 Jun;192(6):926-942. doi: 10.1016/j.ajpath.2022.03.008. Epub 2022 Mar 28.
4
Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.代谢健康型肥胖与良性前列腺增生继发下尿路症状风险增加相关:一项针对中国老年男性的队列研究
Low Urin Tract Symptoms. 2022 May;14(3):170-177. doi: 10.1111/luts.12420. Epub 2021 Dec 9.
5
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor.前列腺周围脂肪细胞释放的转化生长因子β通过上调结缔组织生长因子增强前列腺癌细胞的运动能力。
Biomedicines. 2021 Nov 15;9(11):1692. doi: 10.3390/biomedicines9111692.
6
Longitudinal Changes in Adiposity and Lower Urinary Tract Symptoms Among Older Men.老年人肥胖与下尿路症状的纵向变化。
J Gerontol A Biol Sci Med Sci. 2022 Oct 6;77(10):2102-2109. doi: 10.1093/gerona/glab227.
7
Obesity, metabolic health, and urological disorders in adults: a nationwide population-based study.肥胖、代谢健康和成年人的泌尿科疾病:一项全国范围内基于人群的研究。
Sci Rep. 2021 Apr 22;11(1):8687. doi: 10.1038/s41598-021-88165-z.
8
The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related Disorders.前列腺周围脂肪组织在血管相关疾病中对前列腺功能的作用。
Front Pharmacol. 2021 Feb 12;12:626155. doi: 10.3389/fphar.2021.626155. eCollection 2021.
9
High-Carbohydrate Diet Enhanced the Anticontractile Effect of Perivascular Adipose Tissue Through Activation of Renin-Angiotensin System.高碳水化合物饮食通过激活肾素-血管紧张素系统增强了血管周围脂肪组织的抗收缩作用。
Front Physiol. 2021 Jan 15;11:628101. doi: 10.3389/fphys.2020.628101. eCollection 2020.
10
Biological functions and therapeutic opportunities of soluble cytokine receptors.可溶性细胞因子受体的生物学功能和治疗机会。
Cytokine Growth Factor Rev. 2020 Oct;55:94-108. doi: 10.1016/j.cytogfr.2020.04.003. Epub 2020 Apr 18.